Press release
Vitiligo Treatment Market 2034: FDA Approvals, Clinical trials, Therapies, Prevalence and Companies by DelveInsight | Pfizer, Clinuvel, Inc., Clinuvel Pharmaceuticals, Bioniz Therapeutics, TAGCyx Biotech
Vitiligo Treatment Market
The Vitiligo market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Vitiligo pipeline products will significantly revolutionize the Vitiligo market dynamics.
To Know in detail about the Vitiligo market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Vitiligo Market Insights
https://www.delveinsight.com/sample-request/vitiligo-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the key facts of the Vitiligo Market Report:
• The Vitiligo market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
• In October 2023, Incyte announced new 52-week data from a Phase IIb clinical trial evaluating the safety and efficacy of povorcitinib (INCB54707), an investigational oral JAK1 inhibitor, in adult patients with extensive nonsegmental vitiligo.
• In October 2023, AbbVie announced that its Phase IIb study evaluating upadacitinib (RINVOQ®) in adults with non-segmental vitiligo (NSV) met the primary endpoint of percent change from baseline in the Facial Vitiligo Area Scoring Index (F-VASI) at week 24 with the 11 mg and 22 mg doses versus placebo
• In April 2024, Incyte and China Medical System Holdings Limited announced that on March 31, 2024, Incyte and CMS entered into a Collaboration and License Agreement for the development and commercialization of povorcitinib to research, develop, register and commercialize the Product in Mainland China, Hong Kong, Macao, Taiwan Region and eleven Southeast Asian countries (the "Territory") and a nonexclusive license to manufacture the Product in CMS' Territory
• The 12 month prevalence of vitiligo in the 7MM was assessed to be 8.2 million in 2023, which is expected to increase during the study period (2020-2034)
• Among EU4 and the UK, Germany had the highest prevalent population of vitiligo, which was about 0.7 M, followed by France, the United Kingdom, while Spain had the lowest prevalence in 2021
• Key Vitiligo Companies: Pfizer, Clinuvel, Inc., Clinuvel Pharmaceuticals, Bioniz Therapeutics, TAGCyx Biotechnologies, Temprian Therapeutics, Aclaris Therapeutics, TWi Biotechnology, Dermavant Sciences, Amgen, Pfizer, Incyte Corporation, and others
• Key Vitiligo Therapies: Ritlecitinib, Afamelanotide, Phimelanotide, BNZ-1, TAGX-0003, TT-01, ATI-1777, AC-1101, Cerdulatinib, AMG 714, Ritlecitinib, Ruxolitinib, and others
Vitiligo Overview
Vitiligo is a long-term skin condition characterized by patches of skin that lose their pigment, resulting in white or light-colored patches. These patches can appear anywhere on the body, but they often occur on areas exposed to the sun, such as the face, hands, arms, feet, and lips. Vitiligo can also affect areas with mucous membranes, such as the inside of the mouth and nose, and the genital area.
Get a Free sample for the Vitiligo Market Report:
https://www.delveinsight.com/report-store/vitiligo-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Vitiligo Market
The dynamics of the Vitiligo market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2020-2034.
Vitiligo Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Vitiligo Epidemiology Segmentation:
The Vitiligo market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Vitiligo
• Prevalent Cases of Vitiligo by severity
• Gender-specific Prevalence of Vitiligo
• Diagnosed Cases of Episodic and Chronic Vitiligo
Download the report to understand which factors are driving Vitiligo epidemiology trends @ Vitiligo Epidemiological Insights
https://www.delveinsight.com/sample-request/vitiligo-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Vitiligo Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Vitiligo market or expected to get launched during the study period. The analysis covers Vitiligo market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Vitiligo Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Vitiligo Therapies and Key Companies
• Ritlecitinib: Pfizer
• Afamelanotide: Clinuvel, Inc.
• Phimelanotide - Clinuvel Pharmaceuticals
• BNZ-1: Bioniz Therapeutics
• TAGX-0003: TAGCyx Biotechnologies
• TT-01: Temprian Therapeutics
• ATI-1777: Aclaris Therapeutics
• AC-1101: TWi Biotechnology
• Cerdulatinib: Dermavant Sciences
• AMG 714: Amgen
• Ritlecitinib: Pfizer
• Ruxolitinib: Incyte Corporation
To know more about Vitiligo treatment, visit @ Vitiligo Medications
https://www.delveinsight.com/sample-request/vitiligo-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Vitiligo Market Drivers
• Increasing awareness
• Demand of novel therapies
• Large patient pool and better healthcare infrastructure
Vitiligo Market Barriers
• Patient compliance
• Chronic nature of disease and long term therapy
• Lack of adequate financial assistance & stringent regulatory procedure
Scope of the Vitiligo Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Vitiligo Companies: Pfizer, Clinuvel, Inc., Clinuvel Pharmaceuticals, Bioniz Therapeutics, TAGCyx Biotechnologies, Temprian Therapeutics, Aclaris Therapeutics, TWi Biotechnology, Dermavant Sciences, Amgen, Pfizer, Incyte Corporation, and others
• Key Vitiligo Therapies: Ritlecitinib, Afamelanotide, Phimelanotide, BNZ-1, TAGX-0003, TT-01, ATI-1777, AC-1101, Cerdulatinib, AMG 714, Ritlecitinib, Ruxolitinib, and others
• Vitiligo Therapeutic Assessment: Vitiligo current marketed and Vitiligo emerging therapies
• Vitiligo Market Dynamics: Vitiligo market drivers and Vitiligo market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Vitiligo Unmet Needs, KOL's views, Analyst's views, Vitiligo Market Access and Reimbursement
Discover more about therapies set to grab major Vitiligo market share @ Vitiligo market forecast
https://www.delveinsight.com/sample-request/vitiligo-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1. Vitiligo Market Report Introduction
2. Executive Summary for Vitiligo
3. SWOT analysis of Vitiligo
4. Vitiligo Patient Share (%) Overview at a Glance
5. Vitiligo Market Overview at a Glance
6. Vitiligo Disease Background and Overview
7. Vitiligo Epidemiology and Patient Population
8. Country-Specific Patient Population of Vitiligo
9. Vitiligo Current Treatment and Medical Practices
10. Vitiligo Unmet Needs
11. Vitiligo Emerging Therapies
12. Vitiligo Market Outlook
13. Country-Wise Vitiligo Market Analysis (2020-2034)
14. Vitiligo Market Access and Reimbursement of Therapies
15. Vitiligo Market Drivers
16. Vitiligo Market Barriers
17. Vitiligo Appendix
18. Vitiligo Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Trending Reports:
• Exocrine Pancreatic Insufficiency Market: https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-epi-market
• Hearing Implants Market: https://www.delveinsight.com/report-store/hearing-implants-market
• Hyperuricemia Market: https://www.delveinsight.com/report-store/hyperuricemia-market
• Intracranial Pressure Monitoring Devices Market: https://www.delveinsight.com/report-store/intracranial-pressure-monitoring-devices-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Surgical Stapling Devices Market: https://www.delveinsight.com/report-store/surgical-stapling-devices-market
• Thymic Carcinoma Market: https://www.delveinsight.com/report-store/thymus-cancer-market
• Arteriovenous Fistula Market: https://www.delveinsight.com/report-store/arteriovenous-fistula-market
• Energy Based Aesthetic Devices Market: https://www.delveinsight.com/report-store/energy-based-aesthetic-devices-market
• Non Alcoholic Fatty Liver Disease Market: https://www.delveinsight.com/report-store/non-alcoholic-fatty-liver-disease-nafld-market
• Prefilled Syringes Market: https://www.delveinsight.com/report-store/prefilled-syringes-market
• Bone Anchored Hearing Systems Market: https://www.delveinsight.com/report-store/bone-anchored-hearing-systems-market
• Carcinoid Tumor Market: https://www.delveinsight.com/report-store/carcinoid-tumor-market
• Fibrocystic Breast Condition Market: https://www.delveinsight.com/report-store/fibrocystic-breast-condition-market
• Hiatal Hernia Market: https://www.delveinsight.com/report-store/hiatal-hernia-market
• Palmar Hyperhidrosis Market Size: https://www.delveinsight.com/report-store/palmar-hyperhidrosis-market
• Defibrillators Market: https://www.delveinsight.com/report-store/automated-external-defibrillator-aed-market
• Osteoarthritis Market: https://www.delveinsight.com/report-store/knee-osteoarthritis-market
• Xerostomia Market: https://www.delveinsight.com/report-store/xerostomia-market
• Alopecia Market: https://www.delveinsight.com/report-store/alopecia-areata-market
• Anterior Cruciate Ligament Injuries Market: https://www.delveinsight.com/report-store/anterior-cruciate-ligament-injuries-market
• Pediatric Obesity Market: https://www.delveinsight.com/report-store/pediatric-obesity-market
• Dysthymia Market: https://www.delveinsight.com/report-store/major-depressive-disorder-market
• Alpha-mannosidosis Market: https://www.delveinsight.com/report-store/alpha-mannosidosis-market
• Vestibular Schwannoma Market: https://www.delveinsight.com/report-store/vestibular-schwannoma-market
• Chemotherapy Induced Febrile Neutropenia Market: https://www.delveinsight.com/report-store/chemotherapy-induced-febrile-neutropenia-market
• Gaucher Disease Market: https://www.delveinsight.com/report-store/gauchers-disease-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Hearing Aid Devices Market: https://www.delveinsight.com/report-store/hearing-aid-devices-market
• Pressure Ulcers Market Size: https://www.delveinsight.com/report-store/pressure-ulcers-market
• Critical Limb Ischemia Market: https://www.delveinsight.com/report-store/critical-limb-ischemia-market
• Ophthalmic Imaging Equipment Market: https://www.delveinsight.com/report-store/ophthalmic-imaging-equipment-market
• Onycholysis Market: https://www.delveinsight.com/report-store/onychomycosis-market
• Acute Coronary Syndrome Market: https://www.delveinsight.com/report-store/myocardial-infarction-market
• Pruritus Market: https://www.delveinsight.com/report-store/chronic-pruritus-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Pharmaceutical Consulting Companies: https://www.delveinsight.com/consulting
• Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market
• Acute Pulmonary Embolism Market: https://www.delveinsight.com/report-store/acute-pulmonary-embolism-market
• Apraxia Market: https://www.delveinsight.com/report-store/apraxia-market
• Cellulitis Market: https://www.delveinsight.com/report-store/cellulitis-market
• Healthcare Consulting: https://www.delveinsight.com/consulting
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/asco-conference-coverage
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Vitiligo Treatment Market 2034: FDA Approvals, Clinical trials, Therapies, Prevalence and Companies by DelveInsight | Pfizer, Clinuvel, Inc., Clinuvel Pharmaceuticals, Bioniz Therapeutics, TAGCyx Biotech here
News-ID: 3589210 • Views: …
More Releases from DelveInsight Business Research
Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals.
Objective of the Case Study
The…
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics.
According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than…
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies.
Biopsy devices play a crucial role in disease diagnosis by…
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide.
DelveInsight's General Surgery Devices Market Report 2032 provides…
More Releases for Vitiligo
Organic Care Australia Introduces 'Vitiligo Organics' - A Revolutionary Herbal T …
Image: https://www.getnews.info/uploads/39ec7fd227c4937add1acccc27f32c1b.jpg
Organic Care Australia proudly announced the launch of 'Vitiligo Organics' in 2009, a revolutionary herbal treatment that promises new hope for individuals living with vitiligo, a condition characterized by the loss of skin pigmentation resulting in white patches. This innovative product represents a significant breakthrough in the management of vitiligo, offering a natural, effective solution for those who have long sought an alternative to conventional treatments.
Vitiligo impacts millions worldwide,…
Vitiligo Treatment Market - Unleash Your True Colors: Breakthrough Vitiligo Trea …
Newark, New Castle, USA: The "Vitiligo Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Vitiligo Treatment Market: https://www.growthplusreports.com/report/vitiligo-treatment-market/7780
This latest report researches the industry structure, sales, revenue,…
Vitiligo - Drug Pipeline Landscape, 2022
Vitiligo is a chronic disorder that causes patches of skin to lose pigment or color, when melanocytes are attacked and destroyed, causing the skin to turn a milky-white color. There are two types of vitiligo such as nonsegmental or generalized vitiligo and segmental vitiligo. Nonsegmental or generalized vitiligo happens when the white patches appear symmetrically on both sides of body, such as on both hands or both knees. Segmental vitiligo…
Vitiligo Treatment Market: Rising Impressive Business Opportunities Analysis For …
Vitiligo Treatment Market Report 2022: Industry aims to provide an overview of the industry through detailed market segmentation. The report offers thorough information about the overview and scope of the market along with its drivers, restraints, and trends. This report is designed to include both qualitative and quantitative aspects of the industry in each region and country participating in the study.
Get a Sample PDF of the Report @ https://impeccablemarketresearch.com/enquiry/request-sample-pdf/14636671?utm_source=Openpr&utm_medium=Shubhamko
…
Vitiligo Skin Disorder
Vitiligo Skin Disorder
Vitiligo skin disorder is a skin condition in which white patches on the skin are formed due to malfunctioning of melanocytes, cells that promote pigmentation. http://www.curevitiligooil.com/Vitiligo-Skin-Disorder.htmlThe start of this disease and the grimness of pigment loss vary from person to person. People who have light skin usually witness the loss of pigment in summers because the contrast between depigmented skin and sunburned skin appears distinctive. On the other…
Vitiligo Symptoms
Vitiligo produces macules which are small areas of different skin color. The skin disorder may also produce patches which are flat, pale or white and can't be felt with fingers. (http://www.curevitiligooil.com/Vitiligo-Symptoms.html). These marks frequently expand to form very large, irregularly-shaped areas with no pigmentation. Typically, these are painless and do not itch. The cause of vitiligo symptoms is not known, but autoimmunity may be a factor. Since it is a…
